RxSight (NASDAQ: RXST) revenue
RxSight reported revenue of $134.5m for fiscal 2025, 3.9% less than in fiscal 2024 ($139.9m). Since fiscal 2020 its revenue has grown by 816.2%, an average growth of 55.7% a year.
RxSight's best year of the last 6 was fiscal 2024. The biggest drop was in fiscal 2025, −3.9%.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Revenue by fiscal year
| Fiscal year | Revenue | Change | Operating profit | Operating margin |
|---|---|---|---|---|
| 2025 | $134.5m | −3.9% | −$48.2m | −35.8% |
| 2024 | $139.9m | +57.1% | −$36.9m | −26.3% |
| 2023 | $89.1m | +81.8% | −$50.1m | −56.2% |
| 2022 | $49.0m | +116.9% | −$63.3m | −129.2% |
| 2021 | $22.6m | +53.9% | −$52.8m | −233.6% |
| 2020 | $14.7m | — | −$35.4m | −241.3% |
The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
RxSight revenue compared with its sector
By revenue for its latest fiscal year, RxSight ranks 271st of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; RxSight, −3.9%.
| Rank | Company | Revenue | Revenue growth |
|---|---|---|---|
| 269th | Quanterix | $138.9m | 1.1% |
| 270th | NRC Health | $137.4m | −4.0% |
| 271st | RxSight | $134.5m | −3.9% |
| 272nd | Lifecore Biomedical | $128.9m | 0.5% |
| 273rd | Xencor | $125.6m | 13.7% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the revenue of RxSight
- How much revenue did RxSight make in fiscal 2025?
- RxSight reported revenue of $134.5m for fiscal 2025, compared with $139.9m in fiscal 2024.
- How much has the revenue of RxSight grown?
- Between fiscal 2020 and fiscal 2025 it went from $14.7m to $134.5m: 816.2% more, an average growth of 55.7% a year.
- What was the best year for revenue at RxSight?
- Of its last 6 fiscal years, fiscal 2024, with $139.9m.
- Where does RxSight rank in its sector by revenue?
- It ranks 271st of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
- Where do the figures for RxSight come from?
- From the annual report (Form 10-K) that RxSight files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that RxSight files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020. More on RxSight: the RxSight page · annual accounts · net income · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.